ThermoGenesis announced that the company is rolling out a new facility in the Sacramento metro area, containing a total of 12, class-7, ReadyStart cGMP Suites available for lease by early-stage life science and cell gene therapy companies. The roll-out of the ReadyStart Suites is part of ThermoGenesis’ previously announced plan to transform from a medical device company to a contract development and manufacturing organization in the cell gene therapy field. The facility is expected to be available for customers in the second or third quarter of this year. If fully occupied, the facility is anticipated to generate an estimated $10M-16M in annual revenue.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on THMO:
